[go: up one dir, main page]

WO2010038145A3 - Kit pour l’optimisation de synthèse/sécrétion de protéine - Google Patents

Kit pour l’optimisation de synthèse/sécrétion de protéine Download PDF

Info

Publication number
WO2010038145A3
WO2010038145A3 PCT/IB2009/007021 IB2009007021W WO2010038145A3 WO 2010038145 A3 WO2010038145 A3 WO 2010038145A3 IB 2009007021 W IB2009007021 W IB 2009007021W WO 2010038145 A3 WO2010038145 A3 WO 2010038145A3
Authority
WO
WIPO (PCT)
Prior art keywords
kit
secretion
optimisation
protein synthesis
coding sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2009/007021
Other languages
English (en)
Other versions
WO2010038145A2 (fr
Inventor
John E. Hesketh
Ian Fraser Pryme
Beate Stern
Hanne Ravneberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unitargeting Research AS
Original Assignee
Unitargeting Research AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unitargeting Research AS filed Critical Unitargeting Research AS
Priority to EP09786284.1A priority Critical patent/EP2344524B1/fr
Priority to US13/122,378 priority patent/US9018001B2/en
Publication of WO2010038145A2 publication Critical patent/WO2010038145A2/fr
Publication of WO2010038145A3 publication Critical patent/WO2010038145A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/48—Vector systems having a special element relevant for transcription regulating transport or export of RNA, e.g. RRE, PRE, WPRE, CTE

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La présente invention concerne un kit destiné à être utilisé pour l’identification d’une cassette de sécrétion, qui, dans des cellules eucaryotes, produit un taux plus élevé de synthèse/sécrétion d’une protéine d’intérêt, dont la séquence codante est flanquée par le premier et le second ensemble d’éléments génétiques, respectivement, comparée aux autres cassettes de sécrétion présentes dans le kit contenant la séquence codante à la position correspondante, ainsi qu’un procédé dans lequel le kit est utilisé et l’utilisation dudit kit, de telle manière que la meilleure cassette de sécrétion soit obtenue.
PCT/IB2009/007021 2008-10-02 2009-10-01 Kit pour l’optimisation de synthèse/sécrétion de protéine Ceased WO2010038145A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP09786284.1A EP2344524B1 (fr) 2008-10-02 2009-10-01 Kit pour l optimisation de synthèse/sécrétion de protéine
US13/122,378 US9018001B2 (en) 2008-10-02 2009-10-01 Kit for the optimisation of protein synthesis/secretion

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US10213108P 2008-10-02 2008-10-02
US61/102,131 2008-10-02
SE0802078-6 2008-10-02
SE0802078 2008-10-02
SE0900297-3 2009-03-09
SE0900297 2009-03-09

Publications (2)

Publication Number Publication Date
WO2010038145A2 WO2010038145A2 (fr) 2010-04-08
WO2010038145A3 true WO2010038145A3 (fr) 2010-05-27

Family

ID=41800691

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2009/007021 Ceased WO2010038145A2 (fr) 2008-10-02 2009-10-01 Kit pour l’optimisation de synthèse/sécrétion de protéine

Country Status (3)

Country Link
US (1) US9018001B2 (fr)
EP (1) EP2344524B1 (fr)
WO (1) WO2010038145A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011018766A1 (fr) * 2009-08-12 2011-02-17 Unitargeting Research As Bibliothèque rationnelle
WO2013143698A1 (fr) * 2012-03-27 2013-10-03 Curevac Gmbh Molécules d'acide nucléique artificielles
GB201518792D0 (en) * 2015-10-23 2015-12-09 Univ Manchester Production of proteins
PE20191203A1 (es) * 2016-09-12 2019-09-10 Genethon Variantes de alfa-glucosidasa acida y usos de las mismas
IL257269A (en) * 2018-01-31 2018-04-09 Olender Tsviya Signaling is directed to the endoplasmic reticulum

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002068660A1 (fr) * 2001-02-20 2002-09-06 Aventis Pharma Deutschland Gmbh Proteine de fusion destinee a la secretion d'une proteine d'interet dans le surnageant de la culture bacterienne
WO2005001099A2 (fr) * 2003-06-25 2005-01-06 Unitargeting Research As Systeme d'expression de proteine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002068660A1 (fr) * 2001-02-20 2002-09-06 Aventis Pharma Deutschland Gmbh Proteine de fusion destinee a la secretion d'une proteine d'interet dans le surnageant de la culture bacterienne
WO2005001099A2 (fr) * 2003-06-25 2005-01-06 Unitargeting Research As Systeme d'expression de proteine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
J-L VEYRUNE ET AL: "A localisation signal in the 3' untranslated region of c-mac mRNA targets c-myc mRNA and beta-globin reporter sequences to the prinuclear cytoplasm and cytoskeletal-bound polysomes", JOURNAL OF CELL SCIENCE, CAMBRIDGE UNIVERSITY PRESS, LONDON, GB, vol. 109, 1 January 1996 (1996-01-01), pages 1185 - 1194, XP002086116, ISSN: 0021-9533 *
KRISTINE A PARTRIDGE ET AL: "Competition between the signal sequence and a 3'UTR localisation signal during redirection of beta-globin mRNA to the endoplasmic reticulum: implications for biotechnology", CYTOTECHNOLOGY, KLUWER ACADEMIC PUBLISHERS, DO, vol. 30, no. 1-3, 1 May 1999 (1999-05-01), pages 37 - 47, XP019236605, ISSN: 1573-0778 *

Also Published As

Publication number Publication date
US20110262905A1 (en) 2011-10-27
EP2344524B1 (fr) 2019-12-04
WO2010038145A2 (fr) 2010-04-08
EP2344524A2 (fr) 2011-07-20
US9018001B2 (en) 2015-04-28

Similar Documents

Publication Publication Date Title
WO2011163423A3 (fr) Procédés et compositions pour inhibiteur de stat3 capable de perméation cellulaire
IL192277A (en) Pharmaceutical compounds with resistance to cea soluble, specific bivalve-specific antibodies that bind cea, nucleic acid sequences encoding the antibodies, vectors and surrogate cells containing the nucleic acids, as well as processes for their creation, uses and compatible kits
WO2008067423A3 (fr) Procédé d'amélioration de l'introduction d'adn dans des cellules bactériennes
WO2011034935A3 (fr) Biomarqueurs de transcription de réponses biologiques et procédés
WO2010088633A3 (fr) Nouvelles lignées cellulaires et procédés
WO2010001419A3 (fr) Variations du nombre de copies prédictives d’un risque de schizophrénie
WO2011156654A3 (fr) Caractérisation de voies de cellules
EA201300074A1 (ru) Способ получения представляющего интерес соединения
WO2014143744A3 (fr) Microbes produisant des alcaloïdes de benzylisiquinoline (bia) et leurs procédés de fabrication et d'utilisation
WO2007084364A8 (fr) Il-12 améliorée aux fins d'expression dans des cellules mammaliennes
HK1201297A1 (en) Diterpene synthases and method for producing diterpenoids
EP2808393A3 (fr) Cellules de déficience fucosylation
WO2010051049A3 (fr) Gènes et enzymes de glycosylation thermophiles et thermoacidophiles provenant d'alicyclobacillus acidocaldarius et d'organismes apparentés, et procédés
WO2008118392A3 (fr) Plate-formes synthétiques de cellules et leurs procédés d'utilisation
WO2009145945A3 (fr) Gènes et enzymes à métabolisme thermophile et thermoacidophile d'alicyclobacillus acidocaldarius et d'organismes associés et procédés
WO2009145944A3 (fr) Gènes et enzymes transporteurs de glucides thermophiles et thermoacidophiles d’alicyclobacillus acidocaldarius et organismes et procédés associés
WO2011146891A3 (fr) Cd4 humain à domaine unique, soluble, complètement fonctionnel, à haute affinité, anticorps et protéines hybrides associées
WO2009102569A3 (fr) Nouvelles lignées cellulaires et méthodes associées
WO2010038145A3 (fr) Kit pour l’optimisation de synthèse/sécrétion de protéine
WO2009033163A3 (fr) Procédés de diagnostic et de criblage concernant borrelia
WO2010115745A3 (fr) Biomarqueurs, procédés et kits de diagnostic de la polyarthrite rhumatoïde
WO2011085247A3 (fr) Vecteurs et méthodes pour la transduction des lymphocytes b
WO2009134814A3 (fr) Identification de séquences centromères et leurs utilisations
WO2011129462A3 (fr) Extrait de levure contenant γ-glu-x ou γ-glu-x-gly et son procédé de production
WO2008060576A3 (fr) Technologie à base de matrice d'épices pour l'identification de composés

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09786284

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 13122378

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009786284

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 3032/DELNP/2011

Country of ref document: IN